(Q34587764)

3 August 2017

title

Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice (English)

1 reference

3 August 2017

1 reference

reactive oxygen species

1 reference

1 reference

Hironori Yokoyama

1

1 reference

3 August 2017

Sho Takagi

2

1 reference

3 August 2017

Yu Watanabe

3

1 reference

3 August 2017

Hiroyuki Kato

4

1 reference

3 August 2017

Tsutomu Araki

5

1 reference

3 August 2017

publication date

31 January 2008

1 reference

Journal of Neural Transmission

3 August 2017

published in

1 reference

3 August 2017

volume

115

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

831-842

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-008-0019-6

3 August 2017

exact match

0 references

cites work

Parkinson's disease: pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Nitric oxide: a physiologic messenger molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Effects of age on immunohistochemical changes in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Biosynthesis and metabolism of endothelium-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Oxidative stress and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Nitric oxide synthase: Aspects concerning structure and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Cerebral alterations in a MPTP-mouse model of Parkinson?s disease ? an immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Synthesis of nitric oxide in CNS glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Nitric oxide synthases: Roles, tolls, and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Nitric oxide, oxidants, and protein tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Peroxynitrite reactions and formation in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Minocycline enhances MPTP toxicity to dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0019-6

21 January 2018

1 reference

12 December 2020

Hydroxyl radical attack on dopamine

1 reference

12 December 2020

On-off effects in Parkinson's disease: a controlled investigation of ascorbic acid therapy

1 reference

12 December 2020

Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

Mitochondria, oxidative damage, and inflammation in Parkinson's disease

1 reference

12 December 2020

Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.

1 reference

12 December 2020

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

12 December 2020

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

1 reference

12 December 2020

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

1 reference

12 December 2020

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

12 December 2020

Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes.

1 reference

12 December 2020

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

12 December 2020

Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet.

1 reference

12 December 2020

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

1 reference

12 December 2020

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

12 December 2020

Gases as biological messengers: nitric oxide and carbon monoxide in the brain

1 reference

12 December 2020

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

12 December 2020

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

12 December 2020

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

12 December 2020

Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite

1 reference

12 December 2020

10.1007/S00702-008-0019-6

Identifiers

DOI

1 reference

3 August 2017

1 reference